latanoprost 0.05 MG/ML Ophthalmic Solution
latanoprost
RxCUI: 314072
What the CMS Formulary Data Shows for latanoprost 0.05 MG/ML Ophthalmic Solution
Per the CMS 2026 Part D formulary file, latanoprost 0.05 MG/ML Ophthalmic Solution (RxNorm concept RXCUI 314072, generic name latanoprost) appears on 330 distinct formulary files spanning 5,067 Medicare Part D plan offerings - 100% of enrollable Part D products, near-universal placement. Tier placement ranges from Tier 1 to Tier 6, with a cross-plan average of Tier 1.1.
Real-world access to latanoprost 0.05 MG/ML Ophthalmic Solution depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 43% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 2,403,493 Part D beneficiaries filled latanoprost 0.05 MG/ML Ophthalmic Solution in 2023, with total plan-and-beneficiary spending of $215,961,787 and an average per-beneficiary annual cost of $89.85. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry latanoprost 0.05 MG/ML Ophthalmic Solution today.
Coverage Details
- Formularies covering
- 330
- Plans covering
- 5,067
- Coverage rate
- 100%
- Tier range
- Tier 1 – Tier 6
- Average tier
- Tier 1, Preferred Generic
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 43% of formularies
2023 Medicare Spending
- Beneficiaries
- 2,403,493
- Total spending
- $215,961,787
- Avg per beneficiary
- $89.85
Tier Distribution Across Plans
Standalone Drug Plans (PDP) Covering latanoprost 0.05 MG/ML Ophthalmic Solution
2 standalone prescription drug plans include this drug.
| Plan | Insurer | Tier | PA | ST | Premium | States |
|---|---|---|---|---|---|---|
| AARP Medicare Rx Preferred from UHC (PDP) | UNITEDHEALTHCARE INS. CO. & UHC INS. CO. OF NY | T1 | No | No | $0 | - |
| AARP Medicare Rx Preferred from UHC (PDP) | UNITEDHEALTHCARE INS. CO. & UHC INS. CO. OF NY | T1 | No | No | $0 | - |
Medicare Advantage Plans (MA-PD) Covering latanoprost 0.05 MG/ML Ophthalmic Solution
98 Medicare Advantage plans with Part D drug coverage include this drug.
Frequently Asked Questions
Is latanoprost 0.05 MG/ML Ophthalmic Solution covered by Medicare Part D?
Yes, latanoprost 0.05 MG/ML Ophthalmic Solution is covered by 5,067 Medicare Part D plans (100% of all Part D formularies).
What tier is latanoprost 0.05 MG/ML Ophthalmic Solution on Medicare Part D plans?
latanoprost 0.05 MG/ML Ophthalmic Solution averages Tier 1.1 across Part D plans, ranging from Tier 1 to Tier 6.
Does latanoprost 0.05 MG/ML Ophthalmic Solution require prior authorization?
0% of Part D formularies require prior authorization for latanoprost 0.05 MG/ML Ophthalmic Solution. Step therapy: 0%. Quantity limits: 43%.
How much does Medicare spend on latanoprost 0.05 MG/ML Ophthalmic Solution?
In 2023, total Medicare Part D spending on latanoprost 0.05 MG/ML Ophthalmic Solution was $215,961,787, covering 2,403,493 beneficiaries. The average spend per beneficiary was $89.85.
Read our methodology - how this data is sourced, computed, and verified.